BRAIN Biotech AG (ETR:BNN)
2.890
+0.180 (6.64%)
Jun 12, 2026, 5:35 PM CET
BRAIN Biotech AG Revenue
BRAIN Biotech AG had revenue of 11.67M EUR in the quarter ending March 31, 2026, a decrease of -5.64%. This brings the company's revenue in the last twelve months to 48.31M, down -9.73% year-over-year. In the fiscal year ending September 30, 2025, BRAIN Biotech AG had annual revenue of 50.22M, down -9.52%.
Revenue (ttm)
48.31M
Revenue Growth
-9.73%
P/S Ratio
1.31
Revenue / Employee
172.54K
Employees
280
Market Cap
63.14M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 50.22M | -5.28M | -9.52% |
| Sep 30, 2024 | 55.50M | -725.00K | -1.29% |
| Sep 30, 2023 | 56.23M | 5.93M | 11.79% |
| Sep 30, 2022 | 50.30M | 11.07M | 28.23% |
| Sep 30, 2021 | 39.22M | 158.00K | 0.40% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evonik Industries AG | 13.72B |
| LANXESS Aktiengesellschaft | 5.45B |
| Wacker Chemie AG | 5.41B |
| Fuchs SE | 3.57B |
| Verbio SE | 1.78B |
| H&R GmbH & Co. KGaA | 1.21B |
| AlzChem Group AG | 581.10M |
| Uzin Utz SE | 506.39M |